NVHR | National Viral Hepatitis Roundtable
A MELD score is a clinical tool used to determine prognosis in patients with cirrhosis. MELD represents the prognostic model for end-stage liver disease and is based on three blood tests: international normalized ratio (INR), bilirubin, and creatinine (p 457). It estimates an individuals 90-day mortality rate. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- autoimmune hepatitis overlap syndrome
- autoimmune hepatitis pbc overlap
- autoimmune hepatitis vs pbc
- autoimmune hepatitis foods to avoid
- autoimmune hepatitis stages of disease
- autoimmune hepatitis and diet
- autoimmune hepatitis stage 3
- autoimmune hepatitis questions
- can autoimmune hepatitis be reversed
- autoimmune hepatitis symptoms
- autoimmune hepatitis test
- autoimmune hepatitis diet mayo clinic